Anticipation of onset age in familial Parkinson's disease without SCA gene mutations

Parkinsonism and Related Disorders

Volumn 12, Issue 5, 2006, Pages 309-313

  Huang, Yue ^a   Hayes, Michael ^b   Harding, Antony J ^a   Brooks, William S ^a   Fung, Victor S C ^b   Rowe, Dominic ^b   Joffe, Ron ^b   Crimmins, Denis ^c   Hely, Mariese ^b   Halliday, Glenda M ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c GOSFORD HOSPITAL   (Australia)

Author keywords

Anticipation; Autosomal dominant inheritance; Dementia with Lewy bodies; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN;

ADULT; AGED; ALLELE; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CLINICAL FEATURE; DEMENTIA; FAMILY; GENE MUTATION; GENETICS; HUMAN; LEWY BODY; MAJOR CLINICAL STUDY; ONSET AGE; PARKINSON DISEASE; POINT MUTATION; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION;

AGE OF ONSET; AGED; ALPHA-SYNUCLEIN; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC SCREENING; GENOTYPE; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; PARKINSON DISEASE; PENETRANCE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN-SERINE-THREONINE KINASES; SPINOCEREBELLAR ATAXIAS; TRINUCLEOTIDE REPEATS;

EID: 33744513034     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2006.01.002     Document Type: Article

References (44)

1. Wakabayashi K., Hayashi S., Ishikawa A., Hayashi T., Okuizumi K., Tanaka H., Tsuji S., and Takahashi H. Autosomal dominant diffuse Lewy body disease. Acta Neuropathol Berl 96 (1998) 207-210
2. Payami H., and Zareparsi S. Genetic epidemiology of Parkinson's disease. J Geriatr Psychiatry Neurol 11 (1998) 98-106
3. Harding A.J., Das A., Kril J.J., Brooks W.S., Duffy D., and Halliday G.M. Identification of families with cortical Lewy body disease. Am J Med Genet 128B (2004) 118-122
4. Denson M.A., Wszolek Z.K., Pfeiffer R.F., Wszolek E.K., Paschall T.M., and McComb R.D. Familial parkinsonism, dementia, and Lewy body disease: study of family G. Ann Neurol 42 (1997) 638-643
5. Spira P.J., Sharpe D.M., Halliday G., Cavanagh J., and Nicholson G.A. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann Neurol 49 (2001) 313-319
6. Singleton A.B., Farrer M., Johnson J., Singleton A., Hague S., Kachergus J., Hulihan M., Peuralinna T., Dutra A., Nussbaum R., Lincoln S., Crawley A., Hanson M., Maraganore D., Adler C., Cookson M.R., Muenter M., Baptista M., Miller D., Blancato J., Hardy J., and Gwinn-Hardy K. Alpha-synuclein locus triplication causes Parkinson's disease. Science 302 (2003) 841
7. Zarranz J.J., Alegre J., Gomez-Esteban J.C., Lezcano E., Ros R., Ampuero I., Vidal L., Hoenicka J., Rodriguez O., Atares B., Llorens V., Gomez Tortosa E., del Ser T., Munoz D.G., and de Yebenes J.G. The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann Neurol 55 (2004) 164-173
8. Gwinn-Hardy K., Singleton A., O'Suilleabhain P., Boss M., Nicholl D., Adam A., Hussey J., Critchley P., Hardy J., and Farrer M. Spinocerebellar ataxia type 3 phenotypically resembling parkinson disease in a black family. Arch Neurol 58 (2001) 296-299
9. Wu Y.R., Lin H.Y., Chen C.M., Gwinn-Hardy K., Ro L.S., Wang Y.C., Li S.H., Hwang J.C., Fang K., Hsieh-Li H.M., Li M.L., Tung L.C., Su M.T., Lu K.T., and Lee-Chen G.J. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet 65 (2004) 209-214
10. Markopoulou K., Wszolek Z.K., and Pfeiffer R.F. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation. Ann Neurol 38 (1995) 373-378
11. Bonifati V., Vanacore N., and Meco G. Anticipation of onset age in familial Parkinson's disease. Neurology 44 (1994) 1978-1979
12. Galvin J.E., Lee S.L., Perry A., Havlioglu N., McKeel Jr. D.W., and Morris J.C. Familial dementia with Lewy bodies: clinicopathologic analysis of two kindreds. Neurology 59 (2002) 1079-1082
13. Payami H., Bernard S., Larsen K., Kaye J., and Nutt J. Genetic anticipation in Parkinson's disease. Neurology 45 (1995) 135-138
14. Plante-Bordeneuve V., Taussig D., Thomas F., Ziegler M., and Said G. A clinical and genetic study of familial cases of Parkinson's disease. J Neurol Sci 133 (1995) 164-172
15. Hughes A.J., Daniel S.E., Kilford L., and Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55 (1992) 181-184
16. McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., and Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47 (1996) 1113-1124
17. Prayson R.A., and Estes M.L. The search for diagnostic criteria in Alzheimer's disease: an update. Cleve Clin J Med 61 (1994) 115-122
18. McKeith I.G., Perry E.K., and Perry R.H. Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on dementia with lewy bodies. Neurology 53 (1999) 902-905
19. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol 56 (1999) 33-39
20. Harding A.J., and Halliday G.M. Simplified neuropathological diagnosis of dementia with Lewy bodies. Neuropathol Appl Neurobiol 24 (1998) 195-201
21. Pulst S.M., Nechiporuk A., Nechiporuk T., Gispert S., Chen X.N., Lopes-Cendes I., Pearlman S., Starkman S., Orozco-Diaz G., Lunkes A., DeJong P., Rouleau G.A., Auburger G., Korenberg J.R., Figueroa C., and Sahba S. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet 14 (1996) 269-276
22. Kawaguchi Y., Okamoto T., Taniwaki M., Aizawa M., Inoue M., Katayama S., Kawakami H., Nakamura S., Nishimura M., Akiguchi I., Kimura J., Narumiya S., and Kakizuka A. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 8 (1994) 221-228
23. Nakamura K., Jeong S.Y., Uchihara T., Anno M., Nagashima K., Nagashima T., Ikeda S., Tsuji S., and Kanazawa I. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10 (2001) 1441-1448
24. Gilks W.P., Abou-Sleiman P.M., Gandhi S., Jain S., Singleton A., Lees A.J., Shaw K., Bhatia K.P., Bonifati V., Quinn N.P., Lynch J., Healy D.G., Holton J.L., Revesz T., and Wood N.W. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365 (2005) 415-416
25. Shelbourne P., Winqvist R., Kunert E., Davies J., Leisti J., Thiele H., Bachmann H., Buxton J., Williamson B., and Johnson K. Unstable DNA may be responsible for the incomplete penetrance of the myotonic dystrophy phenotype. Hum Mol Genet 1 (1992) 467-473
26. Carero-Valenzuela R., Lindblad K., Payami H., Johnson W., Schalling M., Stenroos E.S., Shattuc S., Nutt J., Brice A., and Litt M. No evidence for association of familial Parkinson's disease with CAG repeat expansion. Neurology 45 (1995) 1760-1763
27. Maraganore D.M., Schaid D.J., Rocca W.A., and Harding A.E. Anticipation in familial Parkinson's disease: a reanalysis of 13 United Kingdom kindreds. Neurology 47 (1996) 1512-1517
28. Harding A.J., and Halliday G.M. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol Berl 102 (2001) 355-363
29. Schraen-Maschke S., Brique S., Chartier-Harlin M.C., Brique E., Destee A., and Sablonniere B. Analysis of ERDA1, CTG18.1, and uncloned CAG/CTG repeat sequences in familial Parkinson's disease with anticipation. Am J Med Genet 88 (1999) 738-741
30. Yamaguchi K., Cochran E.J., Murrell J.R., Polymeropoulos M.H., Shannon K.M., Crowther R.A., Goedert M., and Ghetti B. Abundant neuritic inclusions and microvacuolar changes in a case of diffuse Lewy body disease with the A53T mutation in the alpha-synuclein gene. Acta Neuropathol Berl 110 (2005) 298-305
31. Farrer M., Wavrant-De Vrieze F., Crook R., Boles L., Perez-Tur J., Hardy J., Johnson W.G., Steele J., Maraganore D., Gwinn K., and Lynch T. Low frequency of alpha-synuclein mutations in familial Parkinson's disease. Ann Neurol 43 (1998) 394-397
32. Wellenbrock C., Hedrich K., Schafer N., Kasten M., Jacobs H., Schwinger E., Hagenah J., Pramstaller P.P., Vieregge P., and Klein C. NR4A2 mutations are rare among European patients with familial Parkinson's disease. Ann Neurol 54 (2003) 415
33. Kruger R., Kuhn W., Muller T., Woitalla D., Graeber M., Kosel S., Przuntek H., Epplen J.T., Schols L., and Riess O. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet 18 (1998) 106-108
34. Markopoulou K., Wszolek Z.K., Pfeiffer R.F., and Chase B.A. Reduced expression of the G209A alpha-synuclein allele in familial Parkinsonism. Ann Neurol 46 (1999) 374-381
35. Li Y.J., Scott W.K., Hedges D.J., Zhang F., Gaskell P.C., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Pahwa R., Stern M.B., Hiner B.C., Jankovic J., Allen Jr. F.A., Goetz C.G., Mastaglia F., Stajich J.M., Gibson R.A., Middleton L.T., Saunders A.M., Scott B.L., Small G.W., Nicodemus K.K., Reed A.D., Schmechel D.E., Welsh-Bohmer K.A., Conneally P.M., Roses A.D., Gilbert J.R., Vance J.M., Haines J.L., and Pericak-Vance M.A. Age at onset in two common neurodegenerative diseases is genetically controlled. Am J Hum Genet 70 (2002) 985-993
36. DeStefano A.L., Lew M.F., Golbe L.I., Mark M.H., Lazzarini A.M., Guttman M., Montgomery E., Waters C.H., Singer C., Watts R.L., Currie L.J., Wooten G.F., Maher N.E., Wilk J.B., Sullivan K.M., Slater K.M., Saint-Hilaire M.H., Feldman R.G., Suchowersky O., Lafontaine A.L., Labelle N., Growdon J.H., Vieregge P., Pramstaller P.P., Klein C., Hubble J.P., Reider C.R., Stacy M., MacDonald M.E., Gusella J.F., and Myers R.H. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. Am J Hum Genet 70 (2002) 1089-1095
37. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., and Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
38. Oliveira S.A., Scott W.K., Martin E.R., Nance M.A., Watts R.L., Hubble J.P., Koller W.C., Pahwa R., Stern M.B., Hiner B.C., Ondo W.G., Allen Jr. F.H., Scott B.L., Goetz C.G., Small G.W., Mastaglia F., Stajich J.M., Zhang F., Booze M.W., Winn M.P., Middleton L.T., Haines J.L., Pericak-Vance M.A., and Vance J.M. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Ann Neurol 53 (2003) 624-629
39. Tan L.C., Tanner C.M., Chen R., Chan P., Farrer M., Hardy J., and Langston J.W. Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation. Mov Disord 18 (2003) 758-763
40. Poorkaj P., Moses L., Montimurro J.S., Nutt J.G., Schellenberg G.D., and Payami H. Parkin mutation dosage and the phenomenon of anticipation: a molecular genetic study of familial parkinsonism. BMC Neurol 5 (2005) 4
41. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., Stoessl A.J., Pfeiffer R.F., Patenge N., Carbajal I.C., Vieregge P., Asmus F., Muller-Myhsok B., Dickson D.W., Meitinger T., Strom T.M., Wszolek Z.K., and Gasser T. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607
42. Di Fonzo A., Rohe C.F., Ferreira J., Chien H.F., Vacca L., Stocchi F., Guedes L., Fabrizio E., Manfredi M., Vanacore N., Goldwurm S., Breedveld G., Sampaio C., Meco G., Barbosa E., Oostra B.A., and Bonifati V. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365 (2005) 412-415
43. Paisan-Ruiz C., Lang A.E., Kawarai T., Sato C., Salehi-Rad S., Fisman G.K., Al-Khairallah T., St George-Hyslop P., Singleton A., and Rogaeva E. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 65 (2005) 696-700
44. Funayama M., Hasegawa K., Kowa H., Saito M., Tsuji S., and Obata F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 51 (2002) 296-301